The Oxford-AstraZeneca CO VID-19 vaccine has been branded “defective” in a multi-million pound landmark legal action that will suggest claims over its efficacy were “vastly overstated”. The Telegraph has the story.
Continue reading Here
The Oxford-AstraZeneca CO VID-19 vaccine has been branded “defective” in a multi-million pound landmark legal action that will suggest claims over its efficacy were “vastly overstated”. The Telegraph has the story.
Continue reading Here